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Abstract
Objectives: The first asbestos fiber cement plant in Spain operated in Cerdanyola, in
the Barcelona metropolitan area, between 1907 and 1997. We describe clinical and
epidemiological characteristics of patients diagnosed with the malignant asbestos‐
related disease (ARD) in the area of the plant between 2007 and 2016.
Methods: A prospective, descriptive study was undertaken in the 12 municipalities
of the county of Barcelona most proximate to the plant. We describe malignant ARD
cases by time of diagnosis, source of exposure, periods of exposure and latency, and
distribution by sex. Cumulative incidence and age‐standardized incidence rates
(ASIR) are calculated.
Results: Of 477 patients diagnosed with ARD between 2007 and 2016, 128 (26%)
presented with asbestos‐associated malignancy. Pleural mesothelioma was noted in
105 patients (82.0%) with a linear trend Z‐score of −0.2 (NS) in men and 2.7 (P < .01)
in women. The highest ASIRs for malignant ARD (6.1/100 000 residents/year; 95%
confidence interval [CI], 2.2‐13.3) and pleural mesothelioma (4.8/100 000 residents/
year; 95% CI, 1.5‐11.6) occurred in municipalities closest to the focal point of con-
tamination. The origin of malignant ARD was nonoccupational in 32.2% of men and
81.6% of women (P < .001).
Conclusions: More than 20 years after the closure of the fiber cement plant, the
grave consequences of exposure to asbestos remain. The detection of cases of
pleural mesothelioma in men seems to have plateaued whereas in women an as-
cending trend continues, which principally has its origin in nonoccupational
exposures.
K E Y W O R D S
asbestos, epidemiology, mesothelioma
1 | INTRODUCTION
In 1907, the first and largest fiber cement plant in Spain opened in
the town of Cerdanyola in the Barcelona metropolitan area, which
acted as a focal point for contamination until its closure in 1997. In
the 90 years during which it was active, the plant processed 227 365
tonnes of asbestos from several different countries.1 This figure
represents 9% of the total imported by Spain during the 20th cen-
tury. The mineral arrived by sea and was transported by rail from the
port of Barcelona to the plant. It was received in hessian sacks and
stored in the open air in the urban area of the town. Unpacking, dry
milling and manufacture were performed in the plant without the
necessary measures of protection until its closure.2 This industrial
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who lived with the workers and the local population.3,4 Until the end
of the 1980s, residues from the plant's production were used in the
repair of streets and paths of the neighboring towns of Cerdanyola
and Ripollet in substitution for asphalt. It should also be mentioned
that other work activities in the area, such as building, smelting,
brake and clutch industries, and plumbing, also made use of asbestos.
Given the long persistence of asbestos and the prolonged period
of latency of asbestos‐related related diseases (ARD), these diseases
will continue to appear in Europe until the mid‐21st century.5
Our group performed a retrospective study in Cerdanyola and its
surrounding municipalities3 that enumerated ARD cases diagnosed
between 1976 and 2006 in the primary healthcare area of the po-
pulation close to the fiber cement plant. Following on from this, a
prospective protocol was designed.6 The objective of the present
study was to describe the incidence of malignant ARD in the sub-
sequent10 years.
2 | METHODS
We undertook a prospective, descriptive study based on an analysis
of all the cases of malignant ARD from all centers of primary
healthcare and the only hospital of reference in the zone (Parc Taulí
Hospital, Sabadell), diagnosed between 2007 and 2016. The study
included the 12 closest municipalities to the principal point of con-
tamination, the fiber cement plant located between Cerdanyola and
Ripollet. We considered two areas: the first covered the area within
2000 m of the factory belonging to Cerdanyola and Ripollet munici-
palities, with the second and larger area, between 2000 and
10 000 m from the factory, within other surrounding municipalities.
The patients were all evaluated and followed by their family practi-
tioner and/or a pulmonologist. The diagnosis of ARD was validated by
our team, who completed a data‐gathering sheet following our pro-
tocol.6 When additional information was required to complete the
sheet, the patient or a family member was contacted. Cases were
considered positive for ARD if the disease met two conditions: (a) the
diagnosis was made by clinical and epidemiological criteria, imaging,
and/or morphological techniques (cytology or histology), and (b)
other diagnostic possibilities had been excluded.3,4 When a single
patient had both benign findings (pleural plaques, pachypleuritis/
pleural thickening, rounded atelectasis, benign pleural effusion, or
asbestosis) and malignant disease at the time of diagnosis, for the
purposes of this study the subject was recorded as having malignant
ARD. In the case of malignancy (pleural mesothelioma, peritoneal
mesothelioma, bronchopulmonary cancer, and laryngeal cancer),
cases were only considered positive with histological confirmation.
The presence of other findings compatible with ARD was also re-
quired to record a case of bronchopulmonary or laryngeal cancer in
patients with exposure due to shared accommodation or environ-
mental exposure.
Patients were classified by their source of exposure as: (a) occu-
pational (the presentation of reliable documentation demonstrating
occupational activity of the worker with exposure to asbestos); (b)
shared accommodation (having habitually shared one's residence with
a worker who was occupationally exposed to asbestos); (c) environ-
mental. If a patient was subject to more than one type of exposure, he
or she was assigned to the exposure group that presumably had the
most intense exposure: occupational, shared accommodation, and
environmental in that order. For occupational source cases, the
duration of exposure was recorded as the time working in an occu-
pational activity whereas for cases with a shared accommodation
source as the time spent in shared living quarters with a worker ex-
posed to asbestos. For environmental cases, the duration of exposure
was established as the time living in the area of the asbestos cement
plant between 1907 and 1997. The latency period was the time from
the start of the exposure until diagnosis. For environmental cases,
exposure was defined as starting in the year that the patient estab-
lished residence in the asbestos cement plant area. This 10 000‐m area
is situated in Catalonia, a region in the northeast of Spain. This is a
mostly industrial area of 449 767 inhabitants, 49.4% of whom are men,
with an average age of 40.1 years.
The study was conducted in accordance with the rules estab-
lished by the Declaration of Helsinki and the Code of Good Scientific
Practice of the Carlos III Institute of Health. The protocol was ap-
proved by the Clinical Research Ethical Committee of the Institut
d'Investigació en Atenció Primària (IDIAP) Jordi Gol of Catalonia. The
participants received written information and were informed of the
implications of the study before giving their consent to participate.
Confidentiality and anonymization of data were in accordance with
Spanish personal data protection regulations.
2.1 | Statistical analysis
Data analysis was performed using the SPSS statistical package.7
Population data from the municipalities included during the period of
study were obtained from the Statistical Institute of Catalonia.8
Cumulative incidence rates (CI) were calculated using annual case
counts by year of diagnosis between 2007 and 2016. The population
according to the 2011 census was used for the denominator: 449 767
inhabitants for the whole area, of which 95 595 lived in the towns of
Cerdanyola and Ripollet. CI rates were applied to the standardized
world population to calculate the age‐standardized incidence rate
(ASIR). Exact confidence intervals were calculated using the inverse
of Fisher's F test and χ2 functions.9,10 Results are provided for the
overall zone of the study and by proximity to the principal focus of
contamination. A Z‐score test of the number of cases of pleural
mesothelioma diagnosed during the period of the study was per-
formed to determine the time trend of incident cases.11
3 | RESULTS
Of a total of 477 patients with ARD, 128 (26.8%) presented with a
malignant ARD, with an overall mean age at diagnosis of 70.9 ± 10.8
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The age at diagnosis of malignant ARD varied significantly de-
pending on the source of exposure and was lower in exposure
through shared accommodation (62.8 ± 10.3) and higher in occupa-
tional cases (72.9 ± 9.4) (P < .001). The number of patients with
pleural mesothelioma was 105 (70 men, 35 women). Although the
time trend of this disease was not significant during the period stu-
died in men (Z for linear trend = −0.21; pNS),
Q3
it showed a significant
progressive increase for women (Z = 2.68; P < .01) (Figure 1). It
should be noted that 12 (3.4%) of the patients initially diagnosed with
a benign pathology later presented a malignant disorder during the
period of the study. The time after the initial benign diagnosis until
the presentation of malignancy was 3.2 ± 2.0 years. In the case of
pleural mesothelioma, the 10‐year birth cohort with the most cases
was the decade 1940 to 1949 in men and the decade 1930 to 1939 in
women, for both those who were exposed occupationally and non-
occupationally. For cohorts born after 1960, the number of cases
dropped notably for both sexes and for all types of exposure.
The ASIR for pleural mesothelioma in the Cerdanyola‐Ripollet
area, which is the closest to the main focus, was 4.8 per 100 000
residents per year (1.5‐11.6) and 1.1 (0.0‐5.9) in the remaining mu-
nicipalities (Table 1). The female/male ratio of cases of pleural me-
sothelioma in the Cerdanyola‐Ripollet area was 0.66, whereas in the
other municipalities, it was 0.35.
Of the 128 patients with malignant ARD, 68 (53.1%) (61 men, 7
women) had been exposed occupationally. Of these, 31 were workers in
the fiber cement plant, and 37 worked for other companies or engaged
in activities related to the handling of asbestos. Of the 105 cases of
pleural mesothelioma, 51 (48.6%) (46 men, 5 women) had occupational
exposure, whereas 54 (51.4%) (24 men, 30 women) had nonoccupational
exposure. Nonoccupational exposure in cases of malignant ARD was
more common in women than in men (85.7% and 34.3%, respectively).
Therefore, the type of exposure in cases of pleural mesothelioma varied
by sex (χ2: 24.71; P < 0.001). In patients with bronchopulmonary cancer
or peritoneal mesotheliomas, occupational exposure was 72.2% and
80.0%, respectively. In patients with occupational exposure, broncho-
pulmonary cancer/pleural mesothelioma ratio was 0.42 in the
Cerdanyola‐Ripollet area and 0.16 in the remainder of the municipalities.
The types of ARD and the times of exposure and latency by the
source of exposure are shown in Table 2. Of the 38 malignant ARD
cases with environmental exposure, 28 (74%) had lived mainly in the
proximate area of the plant (within 2000 m) and 10 in the area from
2000 to 10 000 m.
In patients with pleural mesothelioma, the meantime of exposure
was 16.8 ± 9.1 years in the case of patients who had been exposed
through shared accommodation, 20.1 ± 15.0 for the occupational
cases and 32.6 ± 19.3 for persons who had environmental exposure
(P < .001). In patients with pulmonary cancer, the exposure time was
greater (47.3 ± 13.3 years) in those who were exposed en-
vironmentally. The latency time for malignant ARD and pleural me-
sothelioma was 50.2 ± 13.8 and 50.8 ± 13.9 years, and there were no
significant differences in latency between the different types of
exposure.
4 | DISCUSSION
This study describes the significant impact of a focal point of as-
bestos production and exposure that was active until 1997 on the
population that lived in the surrounding area during a period be-
tween 10 and 20 years after closure. The cumulative incidence of
pleural mesothelioma was 2.3 patients per 100 000 inhabitants per
year, although the incidence was 5.8/100 000/year in the
Cerdanyola‐Ripollet area. These figures exceed the incidence figures
of 1.5 and 4.7, respectively, that were estimated in the area in the
2000 to 2006 period.3 Furthermore, these results represent a much
higher CI than is estimated for the whole of Spain, which was 0.41
between 1994 and 201012 and 0.7 between 2000 and 2015.13
Our study also shows that 20 years after the closure of the fiber
cement plant, 51.4% of the cases of pleural mesothelioma were of
nonoccupational origin. Similar situations of environmental con-
tamination from a fiber cement plant in Casale Monferrato in Italy
have resulted in epidemics of environmental pleural mesothelioma.14
A recent review also confirms the high risk of pleural mesothelioma











































































































F IGURE 1 Patients with pleural
mesothelioma, by the year of diagnosis.
Linear trend* in the 2007 to 2016 time
period. *Trend Z‐score not significant for
men (Z = −0.2081; P = .8352); positive and
significant for women (Z = 2.6776;
P = .0074)
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circumstances.15 The long latency period from first exposure to di-
agnosis for pleural mesothelioma was 50.8 years, which may be re-
levant to predictions about the mesothelioma epidemic.
The number of new cases of pleural mesothelioma in men does
not show a significant time trend within the period from 2007 to
2016, whereas it is significantly positive in women. This possibly
suggests that after a prior period of increase, a plateau was reached
in the case of men, as other authors had anticipated.1,5,16,17 There-
fore, the trend in men is still not decreasing. On the other hand, a
significant upward trend is still observed in women. However, due to
the relatively small number of cases, other studies are needed to
confirm these results. The delay in reaching a plateau in the case of
women could be due to the fact that most mesotheliomas in a woman
(85.7%) were due to nonoccupational exposure, with a longer mean
time of exposure and intensity of exposure that was lower than in
those who were exposed occupationally, who were mainly men. In
other countries, a continuing increase in pleural mesotheliomas of
nonoccupational origin was also observed in women years after the
closure of the principal focal point of contamination.18,19 The female/
male ratio of pleural mesothelioma that was observed is higher in
proximity to the factory than in the municipalities that were more
distant. This would indicate that the environmental risk diminishes as
the distance from the focal point increases, while it is logical that the
occupational risk, which is more frequent in men, persists in the more
distant areas. This finding corresponds with the results obtained in
other studies,13,20 which observe that the proportion of women is
higher when there is intense environmental exposure.
The bronchopulmonary cancer/pleural mesothelioma ratio varies
considerably depending on the study.21,22 In a study by Visona
et al,21 as in our own, the ratio is low. This could be due to under-
diagnosis or underreporting in the case of patients whose broncho-
pulmonary cancer could have been attributed to smoking, given that
exposure to asbestos was determined by interview or through ex-











































































































TABLE 2 Malignant asbestos‐related
disease cases, time of exposure, and period
of latency by type of exposure, 2007
to 2016
Total Occupational Cohabiting Environmental P
Malignant ARD
Patients 128 (26.8%) 68 22 38
Exposure time 23.8 ± 16.6 20.5 ± 14.7 16.7 ± 8.9 33.7 ± 19.1 <.001
Latency period 50.2 ± 13.8 47.7 ± 11.0 53.8 ± 8.5 52.8 ± 19.1 .1
Pleural mesothelioma
Patients 105 (22.0%) 51 21 33
Exposure time 23.4 ± 16.7 20.1 ± 15.0 16.8 ± 9.1 32.6 ± 19.3 <.001
Latency period 50.8 ± 13.9 48.7 ± 10.4 53.9 ± 8.7 52.1 ± 20.0 .3
Peritoneal mesothelioma
Patients 5 (1.0%) 4 1
Exposure time 14.8 ± 12.1 14.8 ± 14.0 15.0 1
Latency period 41.7 ± 10.1 41.7 ± 11.6 42.0 1
Lung cancer
Patients 18 (3.8%) 13 1 4
Exposure time 28.6 ± 16.7 23.9 ± 14.0 15.0 47.3 ± 13.3 <.05
Latency period 49.1 ± 13.3 45.2 ± 12.6 52.0 60.8 ± 10.7 .1
Benign ARD
Patients 349 (73.2%) 177 86 86
Exposure time 22.5 ± 14.9 18.3 ± 12.7 19.6 ± 8.9 34.2 ± 17.6 <.0001
Latency period 53.2 ± 11.6 47.3 ± 8.8 59.5 ± 8.0 59.0 ± 13.4 <.0001
All forms of ARD
Patients 477 (100%) 245 (51.4%) 108 (22.6%) 124 (26.0%)
Exposure time 22.9 ± 15.4 18.9 ± 13.3 19.0 ± 9.0 34.0 ± 18.0 <.0001
Latency period 52.4 ± 12.3 47.4 ± 9.4 58.4 ± 8.4 57.1 ± 15.6 <.0001
Note: Values expressed as the number of patients and % of total. Time of exposure and latency period
expressed in mean years ± standard deviation.
Abbreviation: ARD, asbestos‐related disease.
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asbestos workers can be of occupational origin.23 In contrast, in a
cohort study22 in which occupational exposure had been previously
evaluated, the bronchopulmonary cancer/pleural mesothelioma ratio
was higher. Other authors24,25 note that this ratio could also be af-
fected by different pathogenic mechanisms depending on the type of
asbestos.
Our investigation confirms the rarity of peritoneal mesothelioma
when exposure is not occupational, given that this location is habi-
tually associated to a very high level of exposure to asbestos. The CI
of peritoneal mesothelioma was 0.4 cases per 100 000 men for those
in close proximity to the plant, which is similar to that found in other
areas with intense exposure to asbestos.26
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